Lyra Therapeutics

(NASDAQ) LYRA

Current PriceN/A

Market CapN/A

Since IPO (2020)-100%

5 Year-100%

1 Year-86%

1 Month+45%

Lyra Therapeutics Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$398.00K

Net Income (TTM)

$28.92M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

LYRA News

Lyra Therapeutics Posts 85% Q2 Loss Drop

Motley Fool Markets TeamAug 12, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Lyra Therapeutics

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Maria Palasis, PhD

Website

www.lyratherapeutics.com

Headquarters

Watertown, MA 02472, US

LYRA Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

-78%

Net Income Margin

-73%

Return on Equity

12%

Return on Capital

-1%

Return on Assets

-80%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

$31.02M

EBITDA

$31.02M

Operating Cash Flow

$28.86M

Capital Expenditure

$116.00K

Free Cash Flow

$28.98M

Cash & ST Invst.

$15.89M

Total Debt

$30.26M

Lyra Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$7.00K

-96.7%

Gross Profit

$91.00K

-143.5%

Gross Margin

-13.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$6.95M

+36.7%

EBITDA

$10.08M

-4.8%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$14.37M

-331.8%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$25.44M

-15.9%

Short Term Debt

$4.82M

+16.9%

Return on Assets

-80.09%

N/A

Return on Invested Capital

-1.17%

N/A

Free Cash Flow

$6.16M

+45.4%

Operating Cash Flow

$6.07M

+46.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RNAZTransCode Therapeutics, Inc.

RNAZTransCode Therapeutics, Inc.$8.45-0.82%

INABIN8bio, Inc.

INABIN8bio, Inc.$1.53-1.92%

GLTOGalecto, Inc.

GLTOGalecto, Inc.$24.28-4.78%

BOLTBolt Biotherapeutics, Inc.

BOLTBolt Biotherapeutics, Inc.$4.84-2.42%

CLRBCellectar Biosciences, Inc.

CLRBCellectar Biosciences, Inc.$2.56-1.92%

HCWBHCW Biologics Inc.

HCWBHCW Biologics Inc.$0.40-8.88%

APVOAptevo Therapeutics Inc.

APVOAptevo Therapeutics Inc.$4.91-0.30%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$11.30+0.05%

POETPoet Technologies

POETPoet Technologies$8.03+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$60.74-0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.14-0.01%

SOFISoFi Technologies

SOFISoFi Technologies$18.36-0.02%

RIGTransocean

RIGTransocean$6.79+0.04%

JOBYJoby Aviation

JOBYJoby Aviation$8.93-0.01%

Questions About LYRA

What is the current price of Lyra Therapeutics?

Lyra Therapeutics is trading at N/A per share.

What is the 52-week range for Lyra Therapeutics?

Over the past 52 weeks, Lyra Therapeutics has traded between N/A and N/A.

How much debt does Lyra Therapeutics have?

As of the most recent reporting period, Lyra Therapeutics reported total debt of $30.26M.

How much cash does Lyra Therapeutics have on hand?

Lyra Therapeutics reported $15.89M in cash and cash equivalents in its most recent financial results.

What is Lyra Therapeutics’s dividend yield?

Lyra Therapeutics does not currently have a dividend yield.

Lyra Therapeutics

Lyra Therapeutics Financials at a Glance

LYRA News

Lyra Therapeutics Posts 85% Q2 Loss Drop

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Lyra Therapeutics

LYRA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Lyra Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About LYRA

What is the current price of Lyra Therapeutics?

What is the 52-week range for Lyra Therapeutics?

How much debt does Lyra Therapeutics have?

How much cash does Lyra Therapeutics have on hand?

What is Lyra Therapeutics’s dividend yield?

Premium Investing Services